Deerfield Management Company, L.P. (Series C) Deciphera Pharmaceuticals, Inc. Transaction History

Deerfield Management Company, L.P. (Series C)

$5.38 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$13.58 - $17.36 $8.97 Million - $11.5 Million	-660,754 Reduced 11.42%	5,127,270 $80.7 Million
Q4 2023 Feb 14, 2024	SELL	$10.11 - $16.54 $11.2 Million - $18.4 Million	-1,109,582 Reduced 16.09%	5,788,024 $93.4 Million
Q3 2023 Nov 14, 2023	BUY	$12.46 - $15.48 $2.37 Million - $2.95 Million	190,580 Added 2.84%	6,897,606 $87.7 Million
Q2 2023 Aug 14, 2023	BUY	$13.28 - $15.96 $19.8 Million - $23.8 Million	1,488,388 Added 28.52%	6,707,026 $94.4 Million
Q1 2023 May 15, 2023	BUY	$14.26 - $22.1 $40.9 Million - $63.4 Million	2,869,410 Added 122.14%	5,218,638 $80.6 Million
Q4 2022 Feb 14, 2023	SELL	$14.85 - $19.04 $2.11 Million - $2.71 Million	-142,262 Reduced 5.71%	2,349,228 $38.5 Million
Q3 2022 Nov 14, 2022	SELL	$12.38 - $20.23 $46.5 Million - $76.1 Million	-3,759,474 Reduced 60.14%	2,491,490 $46.1 Million
Q2 2022 Aug 15, 2022	BUY	$9.11 - $13.98 $6.11 Million - $9.37 Million	670,508 Added 12.02%	6,250,964 $82.2 Million
Q4 2021 Feb 14, 2022	BUY	$7.7 - $37.13 $36.7 Million - $177 Million	4,765,456 Added 584.72%	5,580,456 $54.5 Million
Q3 2021 Nov 15, 2021	SELL	$26.46 - $37.15 $14 Million - $19.6 Million	-528,560 Reduced 39.34%	815,000 $27.7 Million
Q2 2021 Aug 16, 2021	BUY	$32.73 - $47.95 $26.7 Million - $39.1 Million	814,975 Added 154.18%	1,343,560 $49.2 Million
Q3 2020 Nov 16, 2020	BUY	$43.8 - $58.16 $4.68 Million - $6.22 Million	106,906 Added 25.35%	528,585 $27.1 Million
Q2 2020 Aug 14, 2020	SELL	$37.05 - $65.03 $6.22 Million - $10.9 Million	-167,806 Reduced 28.47%	421,679 $25.2 Million
Q1 2020 May 15, 2020	BUY	$33.63 - $69.4 $9.47 Million - $19.5 Million	281,485 Added 91.39%	589,485 $24.3 Million
Q4 2019 Feb 14, 2020	SELL	$31.7 - $69.93 $9.09 Million - $20.1 Million	-286,725 Reduced 48.21%	308,000 $19.2 Million
Q3 2019 Nov 14, 2019	SELL	$19.95 - $38.85 $257,514 - $501,475	-12,908 Reduced 2.12%	594,725 $20.2 Million
Q4 2018 Feb 14, 2019	BUY	$19.08 - $36.14 $11.6 Million - $22 Million	607,633 New	607,633 $12.8 Million
Q1 2018 May 15, 2018	SELL	$20.04 - $29.71 $6.73 Million - $9.98 Million	-336,009 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$16.54 - $24.2 $182,088 - $266,417	11,009 Added 3.39%	336,009 $7.62 Million
Q3 2017 Nov 13, 2017	BUY	$17.65 - $18.99 $5.74 Million - $6.17 Million	325,000	325,000 $6.17 Million

Others Institutions Holding DCPH

# of Institutions

Shares Held

293K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account